Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Adacel, Daptacel, Pentacel, Quadracel, Vaxelis
Generic Name
Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)
DrugBank Accession Number
DB10787
Background

Not Available

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Other vaccines
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to preventDiphtheriaCombination Product in combination with: Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796), Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584), Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788), Bordetella pertussis pertactin antigen (DB10789), Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795), Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583), Bordetella pertussis fimbriae 2/3 antigen (DB10790)•••••••••••••••••••••
Used in combination to preventDiphtheriaCombination Product in combination with: Bordetella pertussis pertactin antigen (DB10789), Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788), Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583), Bordetella pertussis fimbriae 2/3 antigen (DB10790), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)•••••••••••••••••••••
Used in combination to preventDiphtheriaCombination Product in combination with: Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797), Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796), Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788), Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (DB10342), Bordetella pertussis fimbriae 2/3 antigen (DB10790), Bordetella pertussis pertactin antigen (DB10789), Hepatitis B Vaccine (Recombinant) (DB11627), Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583), Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)•••••••••••••••••••••
Used in combination to preventDiphtheriaCombination Product in combination with: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583), Bordetella pertussis fimbriae 2/3 antigen (DB10790), Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584), Bordetella pertussis pertactin antigen (DB10789)•••••••••••••••••••••
Used in combination to preventHaemophilus influenzae type b diseasesCombination Product in combination with: Bordetella pertussis fimbriae 2/3 antigen (DB10790), Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584), Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788), Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583), Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795), Bordetella pertussis pertactin antigen (DB10789), Hepatitis B Vaccine (Recombinant) (DB11627), Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796), Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797), Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (DB10342)•••••••••••••••••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ADACEL 0,5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 5 ADETBordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 mcg/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg/0.5mL) + Bordetella pertussis pertactin antigen (3 mcg/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf/0.5mL) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5mL)Injection, solutionIntramuscularSANOFİ PASTEUR AŞI TİC. A.Ş.2017-08-17Not applicableTurkey flag
ADACEL SUSPENSION FOR INJECTIONBordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL)Injection, suspensionIntramuscularSANOFI-AVENTIS (MALAYSIA) SDN. BHD.2020-09-08Not applicableMalaysia flag
Adacel TDaPBordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL)Injection, suspensionIntramuscularSanofi Pasteur Inc.2005-06-10Not applicableUS flag
Adacel TDaP TDaPBordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL)Injection, suspensionIntramuscularRemedy Repack2015-11-142016-03-29US flag
ADACEL- POLIOBordetella pertussis toxoid antigen (glutaraldehyde inactivated) (2.5 ug/0.5mL) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 ug/0.5mL) + Bordetella pertussis fimbriae 2/3 antigen (5 ug/0.5mL) + Bordetella pertussis pertactin antigen (3 ug/0.5mL) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 [Lf]/0.5mL) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 [Lf]/0.5mL) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 [D'ag'U]/0.5ml) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 [D'ag'U]/0.5ml) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 [D'ag'U]/0.5ml)Injection, suspensionIntramuscularSANOFI-AVENTIS (MALAYSIA) SDN. BHD.2020-09-082024-02-24Malaysia flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
F4TN0IPY37
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
4Active Not RecruitingPreventionCervical Carcinoma / Human Papillomavirus (HPV) Infections1somestatusstop reasonjust information to hide
4CompletedPreventionDiphtheria1somestatusstop reasonjust information to hide
4CompletedPreventionDiphtheria / Haemophilus Infections / Pertussis / Poliomyelitis / Tetanus1somestatusstop reasonjust information to hide
4CompletedPreventionDiphtheria / Haemophilus Influenzae Serotype b (Hib) / Meningitis / Meningococcal Infections / Pertussis / Tetanus1somestatusstop reasonjust information to hide
4CompletedPreventionHaemophilus Influenzae Type b (Hib) Infection1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
Injection, suspensionIntramuscular
Injection; injection, suspension; kitIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53